** Shares of medical device company Autonomix Medical
slump 53% to $6.35 in early trading
** AMIX sold ~1.4 mln shares in a public offering at $6.54/shr for gross proceeds of $9 mln
** Offering priced at about 52% discount to stock's last close
** Company has ~1.2 mln outstanding shares for $15.6 mln market capitalization, according to data compiled by LSEG
** Ladenburg Thalmann sole bookrunning manager for the offering
** AMIX plans to use the proceeds to fund its clinical trial, among other purposes
** As of last close, AMIX shares up 170% since debut on Jan. 29 this year
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.